(Z)-3-{4-oxo-2-[(2-oxoindolin-3-ylidene)methyl]-4,5,6,7-tetrahydro-1H-indol-3-yl}propanoic acid | 1235458-08-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (Z)-3-{4-oxo-2-[(2-oxoindolin-3-ylidene)methyl]-4,5,6,7-tetrahydro-1H-indol-3-yl}propanoic acid
• 英文别名: (Z)-3-((3-carboxyethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl)methylene)indolin-2-one；3-[4-oxo-2-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1,5,6,7-tetrahydroindol-3-yl]propanoic acid
• CAS: 1235458-08-8
• 化学式: C₂₀H₁₈N₂O₄
• 分子量: 350.374
• InChiKey: MMGOTJIEBBQFCL-RAXLEYEMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  99.3
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (Z)-ethyl 3-{4-oxo-2-[(2-oxoindolin-3-ylidene)methyl]-4,5,6,7-tetrahydro-1H-indol-3-yl}propanoate 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 2.0h， 生成 (Z)-3-{4-oxo-2-[(2-oxoindolin-3-ylidene)methyl]-4,5,6,7-tetrahydro-1H-indol-3-yl}propanoic acid
  参考文献：
  名称：

  Indolinone Compounds as Kinase Inhibitors

  摘要：

  式(I)或(II)的吲哚酮化合物：其中A，R1，R2，R3，R4，R5，R6，R7和n在此定义。还公开了使用这些化合物降低蛋白激酶活性和治疗蛋白激酶相关疾病，如癌症的方法。

  公开号：

  US20100179146A1

文献信息

• Indolinone Compounds as Kinase Inhibitors
  申请人：Huang Jiann-Jyh

  公开号：US20100179146A1

  公开（公告）日：2010-07-15

  Indolinone compounds of formula (I) or (II): wherein A, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and n are defined herein. Also disclosed are methods for decreasing the activity of a protein kinase and for treating a protein kinase-related disease, such as cancer, with these compounds.

  式(I)或(II)的吲哚酮化合物：其中A，R1，R2，R3，R4，R5，R6，R7和n在此定义。还公开了使用这些化合物降低蛋白激酶活性和治疗蛋白激酶相关疾病，如癌症的方法。
• Indolinone compounds as kinase inhibitors
  申请人：Development Center for Biotechnology

  公开号：US07897602B2

  公开（公告）日：2011-03-01

  Indolinone compounds of formula (I) or (II): wherein A, R1, R2, R3, R4, R5, R6, R7, and n are defined herein. Also disclosed are methods for decreasing the activity of a protein kinase and for treating a protein kinase-related disease, such as cancer, with these compounds.

  式(I)或(II)的吲哚酮化合物： 其中A、R1、R2、R3、R4、R5、R6、R7和n的定义如本文所述。还公开了使用这些化合物降低蛋白激酶活性以及治疗蛋白激酶相关疾病（如癌症）的方法。
• US7897602B2
  申请人：——

  公开号：US7897602B2

  公开（公告）日：2011-03-01
• Discovery of Pyrrole−Indoline-2-ones as Aurora Kinase Inhibitors with a Different Inhibition Profile
  作者：Chao-Cheng Chiang、Yu-Hsiang Lin、Shu Fu Lin、Chun-Liang Lai、Chiawei Liu、Win-Yin Wei、Sheng-chuan Yang、Ru-Wen Wang、Li-Wei Teng、Shih-Hsien Chuang、Jia-Ming Chang、Ta-Tung Yuan、Ying-Shuen Lee、Paonien Chen、Wei-Kuang Chi、Ju-Ying Yang、Hung-Jyun Huang、Chu-Bin Liao、Jiann-Jyh Huang

  DOI：10.1021/jm1001869

  日期：2010.8.26

  A series of pyrrole-indolin-2-ones were synthesized, and their inhibition profile for Aurora kinases was studied. The potent compound 33 with phenylsulfonamido at the C-5 position and a carboxyethyl group at the C-3' position selectively inhibited Aurora A over Aurora B with IC(50) values of 12 and 156 nM, respectively. Replacement of the carboxyl group with an amino group led to compound 47, which retained the activity for Aurora B and lost activity for Aurora A (IC(50) = 2.19 mu M). Computation modeling was used to address the different inhibition profiles of 33 and 47. Compounds 47 and 36 (the ethyl ester analogue of 33) inhibited the proliferation of HCT-116 and HT-29 cells and suppressed levels of the phosphorylated substrates of Aurora A and Aurora B in the Western blots.